Two cases ofthe nephrotic syndrome with an apparently identical defect of blood coagulation, discovered during preparation for renal biopsy are described. Plasma from both patients showed prolongation of thrombin and kaolin cephalin times which was probably due to abnormally slow polymerization of fibrin monomer. Corticosteroid therapy reversed the abnormal times in one case. One of the patients showed seasonal relapses which occurred in relation to episodes of hay fever associated with allergy to grass pollen. The other patient showed some similar features, but on renal biopsy was found to have proliferative glomerulonephritis.
Introduction
The relapsing nephrotic syndrome in association with grass pollen allergy has been reported in a number of children but only 2 adults (Hardwicke et al., 1959; Williamson, 1970; Wittig and Goldman, 1970 ; Reeves et al., 1975 ). An association has been suggested between this disorder and HLA B12 (Thomson et al., 1976) . None of the reported cases has suffered from other disease processes, nor has a defect of blood coagulation been described previously. The 2 patients reported here are of interest in view of the presence of a coagulation disorder which was of an unusual type. The clotting disorder hindered the performance of renal biopsy, a necessary step in the diagnosis and management of the nephrotic syndrome. The first case is also unusual because of the rarity of the atopic nephrotic syndrome occurring in an adult.
Materials and methods

Immunology
Antinuclear factor (ANF) was measured by indirect immunofluorescence, anti-streptolysin O (ASO) by sheep cell haemolysis inhibition. Immunoglobulins and C3 complement were estimated by radial immunodiffusion. Hepatitis B surface antigen (HBSAg) was measured by immunoelectro-osmophoresis and turkey erythrocyte haemagglutination. Skin tests were carried out using the Bencard prick tests. HLA testing was by the NIH lymphocyte microtoxicity technique (NIAID, 1974) .
Biochemistry
Standard biochemical measurements on plasma and urine were made with the Vicker's M300 multichannel analyser. Correction of plasma calcium for plasma albumin concentration was by the method of Payne et al. (1973) . Plasma cholesterol was measured by a modification of the method of Rappaport and Eichhorn (Annan and Isherwood, 1969) .
Coagulation
Tests of coagulation function were performed according to recognized methods detailed elsewhere (Davies, Fieldhouse and McNicol, 1976) . Molecular weight of fibrinogen precipitated from plasma with ammonium sulphate and subunit structure of reduced polymerized fibrin were assessed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulphate (Weber and Osborn, 1969) . Immunoelectrophoresis of fibrinogen was performed on agarose plates at pH 4 and pH 8.6 using commercial antisera (Hoechst Pharmaceuticals, Hounslow) . Rate of release of fibrinopeptide A (FPA) was estimated after collection of native blood into a plastic syringe at room temperature and subsampling into an aprotinin-heparin-EDTA mixture at intervals of 0, 30, 60, 90, 120 and 240 sec. FPA was then assayed by the method described by using commercially-available reagents (IMCO Corporation Limited, Grev Turegatan 8, Stockholm). FXIII was assayed by the amine incorporation technique (Lorand et al., 1969) Subsequent questioning after discovery of the defect in blood coagulation showed that she had never had any episodes of abnormal bruising, or bleeding, and that her menstrual periods had been normal in amount and duration. There was no family history of an abnormal bleeding tendency.
Clinical examination showed a moderate degree of ankle and sacral oedema and the blood pressure was 100/60 mm/Hg. Examination of all other systems was normal and at no time were there any clinical manifestations of a bleeding tendency.
On the basis of the clinical features and the investigations described below, a diagnosis of seasonal nephrotic syndrome was made (see Table  1 ). This was not confirmed by renal biopsy because of the coagulation defect discovered on routine screening. She was treated with bed rest, a thiazide diuretic, and protection from outdoor dusts and allergens. Within (Fig. 1) . The rate of release of fibrinopeptide A from fibrinogen was faster in both patients than in a control subject and this is shown for Case 2 in Fig. 2 .
A few further investigations were performed. 
Discussion
The second case showed high blood eosinophil count, high serum IgE concentration, low serum IgG concentration and normal glomerular filtration rate, features described in patients with atopic nephrotic syndrome (Reeves et al., 1975) , although there was no history of atopy in this patient. He also showed laboratory evidence of a coagulation defect strikingly similar to that found in the first patient. In view of the similarity of the 2 cases and the selectivity of the proteinuria, it was decided to treat him with corticosteroids. The subsequent remission of the coagulation disorder, simultaneously with the improvement in renal function, allowed renal biopsy to be performed. The pathological diagnosis obtained of proliferative glomerulonephritis was unexpected, in view of the otherwise close resemblance to the first case and the rapid response to corticosteroid therapy.
The abnormality of coagulation function was apparently the same in both patients and unusual in type. It was characterized by prolongation of thrombin, kaolin cephalin and reptilase times in the presence of normal concentrations of fibrinogen. characterization of the defect was prevented because the coagulation abnormality rapidly disappeared with treatment of the nephrotic syndrome.
One plausible explanation of the defect is that fibrin monomer polymerized abnormally slowly in both patients. This is supported by the similarity between results of coagulation function tests in these patients and a group with liver disease (Lane et al., 1977) . In the patients reported by Lane While abnormal bleeding is a well recognized feature of renal failure (Kazatchkine et al., 1976) a coagulation defect in the nephrotic syndrome has been described only rarely. Reduced concentrations of factor IX (Rahman, Zanger and Natelson, 1975) and factor VII (Epstein et al., 1976) have been reported. The suggested mechanism for the coagulation disorder in these patients was loss of factor IX and VII in the urine, accompanying the heavy albuminuria. A study of coagulation function in 45 patients with nephrotic syndrome (Kanfer et al., 1970) indicated that increased procoagulant activity of plasma was much commoner than defective haemostatic function. However, prolongation of the thrombin time was a frequent finding. This was thought to be due to increased anti-thrombin activity because there was a close correlation with raised concentrations of a-2-macroglobulin in plasma. The prolonged thrombin time in these patients was also unaffected by remission of the disease or administration of corticosteroid therapy. The defect of coagulation described in the present 2 patients is not explicable on the basis of these earlier reports.
The authors' findings and those previously reported underline the importance of careful screening of the coagulation system in cases of the nephrotic syndrome. Injudicious biopsy in patients similar to those described might easily result in serious haemorrhage from the kidney.
